Vitamin D to Improve Outcomes by Leveraging Early Treatment: Long-term Brain Outcomes in Vitamin D Deficient Patients

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

October 2, 2019

Study Completion Date

February 21, 2020

Conditions
Cognitive Decline
Interventions
DRUG

540,000 IU vitamin D3

This intervention was administered as part of VIOLET parent study. A single dose of 540,000 IU vitamin D3 was administered within 2 hours of randomization time.

DRUG

Placebo

Placebo that matched the vitamin D3 color was provided.

Trial Locations (7)

10467

Montefiore Medical Center, New York

37232

Vanderbilt University Medical Center, Nashville

80045

University of Colorado Hospital, Aurora

84107

Intermountain Medical Center, Murray

97239

Oregon Health and Science University Hospital, Portland

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

Montefiore Medical Center

OTHER

collaborator

Intermountain Medical Center

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

Vanderbilt University Medical Center

OTHER